Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AA-AMILZIDE | 5MG 50MG | TABLET | Resolved | 2022-03-23 | 2022-04-29 | 157133 |
| AA-AMILZIDE | 5MG 50MG | TABLET | Actual shortage | 2024-05-24 | 2024-06-05 | 228768 |
| ZESTORETIC | 12.5MG 10MG | TABLET | Resolved | 2023-06-19 | 2023-07-13 | 195535 |
| ZESTORETIC | 10MG 12.5MG | TABLET | Actual shortage | 2023-08-24 | 2023-12-05 | 202917 |
| ZESTORETIC | 10MG 12.5MG | TABLET | Resolved | 2023-09-15 | 2023-09-20 | 204548 |
| TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2020-03-26 | 2020-04-23 | 109574 |
| TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2020-09-03 | 2021-02-05 | 123738 |
| TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2023-10-26 | 2023-11-09 | 208251 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110697 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110700 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |